Seven New RNAi-related Patent Applications Published by USPTO | GenomeWeb

Title: Novel Nucleic Acid and Polypeptide Molecules. Number: 20030219739. Filed: Jan. 30, 2002. Lead Inventor: David Glass, Regeneron Pharmaceuticals.

The patent application, its abstract states, covers an invention involving “nucleic acid sequences that encode novel mammalian intracellular signaling polypeptides, designated MURF1, MURF3, or MA-61. The invention also provides assays systems that may be used to detect and/or measure agents that bind the MURF1 or MAFBX gene product.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.